Doximity shares jump 60% after CEO cites 4.8% error rate for its clinical AI

AI Market Summary
Doximity's sharp rally after management cited materially lower clinical AI error rates versus Anthropic models signals renewed investor willingness to re-rate specialized healthcare AI platforms despite an earnings miss. The move highlights that perceived model performance and adoption momentum can dominate near-term valuation drivers for AI-related equities, potentially lifting sentiment across the broader AI software and infrastructure complex.
Impact level
● Medium
Affected assets
NCSKOPENAI2USD/USDT+1.58%
AI Insight · NCSKOPENAI2USD/USDTAI Insight
▲ Bullish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Doximity shares surged about 60% after CEO Jeff Tangney said the company’s clinical AI posted a 4.8% error rate in physician-focused testing, versus 13.6% for what he described as Anthropic’s best model. The stock had risen as much as 200% in premarket trading before giving back most of those gains. The move marked a record single-day jump for the shares.